查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1564072

全球细胞计数市场

Cell Counting
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球细胞计数市场将达到 220 亿美元

全球细胞计数市场预计 2023 年为 153 亿美元，预计到 2030 年将达到 220 亿美元，2023-2030 年分析期间复合年增长率为 5.3%。细胞计数耗材是本报告分析的细分市场之一，复合年增长率为 6.0%，预计到分析期结束时将达到 129 亿美元。分析期内，细胞计数设备领域的复合年增长率预计为 4.5%。

美国市场预计将成长42亿美元，中国复合年增长率为5.0%

到 2023 年，美国细胞计数市场预计将达到 42 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达34亿美元，2023-2030年分析期间复合年增长率为5.0%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 5.2% 和 4.1%。在欧洲，德国的复合年增长率预计为 4.3%。

全球细胞计数市场－主要趋势与驱动因素总结

细胞计数如何推动生物技术和医学研究？

细胞数已成为生物技术、生命科学和医学研究的基本技术，为细胞行为、生长和治疗反应提供重要见解。该过程涉及对给定样品中的细胞进行定量，对于从评估药物筛检中的细胞活力到确定细胞培养物中的浓度等广泛应用至关重要。细胞计数在癌症研究等领域至关重要，了解细胞增殖率直接影响新治疗方法的开发。准确的细胞计数在生物製药的生产中也极为重要，需要准确的细胞计数来实现稳定的产品产量和品管。此外，细胞计数广泛应用于免疫学、微生物学和血液学中，以监测疾病进展和治疗性介入的有效性。无论是在研究、诊断或治疗开发中，现代细胞计数的准确性和效率在推进科学知识和医学创新方面发挥着至关重要的作用。

为什么细胞计数自动化技术的需求不断增加？

由于研究和临床环境中对准确性、效率和扩充性的需求，自动细胞计数技术的需求量很大。手动细胞计数通常使用显微镜下的血球计数器进行，非常繁琐，容易出现人为错误，不适合高通量应用。相较之下，自动细胞计数系统可提供快速、准确且可重复的结果，使研究人员和临床医生能够在更短的时间内处理大量样本。这些系统在药物研究中特别有价值，其中快速分析数百至数千个样本的细胞活力和增殖的能力对于药物发现和开发至关重要。此外，生物研究的复杂性不断增加，特别是在肿瘤学、干细胞研究和再生医学等领域，需要更复杂的工具来处理不断增加的细胞实验量。具有先进成像和流式细胞技术功能的自动细胞计数器可透过提供高解析度资料和支援复杂的检测（包括涉及异质细胞群的检测）来满足这些需求。使用者友好的软体介面和整合的资料分析工具使这些系统更具吸引力，并正在推动世界各地实验室和医院的采用。

技术进步如何改变细胞计数技术？

技术的进步正在改变细胞计数，并提高研究人员和临床医生可用工具的准确性和功能性。流式细胞技术、基于影像的细胞计数和微流体设备等创新技术正在实现更精确和高通量的细胞分析。特别是流式细胞技术可以同时对数千个细胞进行计数，并根据其物理和化学特性进行表征，使其成为免疫表型分析和癌症研究等应用的理想选择。基于影像的细胞计数使用复杂的显微镜和软体演算法来分析细胞影像，由于它提供了有关细胞形态和活力的详细资料，因此变得越来越流行。此外，无标定技术的出现不需要染料或染色剂，可以即时监测细胞增殖，减少了外部因素对所研究细胞的影响，保留了它们的自然行为。结合人工智慧（AI）和机器学习的自动化系统正在进一步增强细胞计数技术的能力，基于大资料集提供更准确的细胞行为预测和分析。这些创新使细胞计数更快、更可靠、用途更广泛，扩大了其在研究和临床诊断中的应用。

细胞计数市场的主要成长动力是什么？

细胞计数市场的成长受到多种因素的推动，例如慢性病的增加、生物技术的进步以及个人化医疗需求的不断增长。关键驱动因素之一是疾病调查和诊断中对准确细胞分析的需求不断增长。随着全球癌症、糖尿病和感染疾病的发生率持续增加，细胞计数技术对于监测疾病进展和评估治疗效果至关重要。此外，生物製药行业的扩张，特别是生技药品和疫苗的生产，增加了对精确细胞计数的需求，以确保一致的产品品质。自动化高通量细胞计数系统的开发等技术进步正在提高研究工作流程的速度和准确性，进一步推动市场成长。个人化医疗日益发展的趋势，需要精确的细胞分析来为个别患者量身定制治疗方案，这也推动了对先进细胞计数技术的需求。此外，干细胞在再生医学中的使用越来越多，以及药物开发中基于细胞的检测方法的扩展，都为细胞计数解决方案创造了新的机会。最后，随着医疗保健提供者寻求更准确的患者照护工具，细胞计数技术在临床诊断（尤其是血液学和免疫学）中的采用正在推动市场扩张。这些因素，加上生命科学研究投资的增加，预计未来几年细胞计数市场将保持强劲成长。

受访企业范例（共13例）

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Horiba Ltd.
  • Merck & Co., Inc.
  • PerkinElmer, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP10938

Global Cell Counting Market to Reach US$22.0 Billion by 2030

The global market for Cell Counting estimated at US$15.3 Billion in the year 2023, is expected to reach US$22.0 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Cell Counting Consumables, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$12.9 Billion by the end of the analysis period. Growth in the Cell Counting Instruments segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 5.0% CAGR

The Cell Counting market in the U.S. is estimated at US$4.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 5.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Cell Counting Market - Key Trends and Drivers Summarized

How Is Cell Counting Advancing Research in Biotechnology and Medicine?

Cell counting has become a fundamental technique in biotechnology, life sciences, and medical research, providing critical insights into cellular behavior, growth, and response to treatments. This process involves quantifying cells in a given sample, which is essential for a wide range of applications, from assessing cell viability in drug screening to determining concentrations in cell culture. Cell counting is indispensable in fields such as cancer research, where understanding cell proliferation rates can directly influence the development of new therapies. It is also crucial in biopharmaceutical production, where accurate cell counts are necessary for consistent product yields and quality control. Moreover, cell counting is extensively used in immunology, microbiology, and hematology to monitor disease progression and the effectiveness of therapeutic interventions. Whether for research, diagnostics, or therapeutic development, the precision and efficiency of modern cell counting methods are playing a pivotal role in advancing scientific knowledge and medical innovation.

Why Is There a Growing Demand for Automated Cell Counting Technologies?

The growing demand for automated cell counting technologies stems from the need for accuracy, efficiency, and scalability in both research and clinical settings. Manual cell counting, often performed using a hemocytometer under a microscope, is labor-intensive, prone to human error, and unsuitable for high-throughput applications. In contrast, automated cell counting systems offer rapid, precise, and reproducible results, enabling researchers and clinicians to process large sample volumes in significantly less time. These systems are particularly valuable in pharmaceutical research, where the ability to rapidly analyze cell viability and proliferation across hundreds or thousands of samples is critical for drug discovery and development. Additionally, the rising complexity of biological research, especially in fields like oncology, stem cell research, and regenerative medicine, requires more sophisticated tools to handle the increasing volume of cell-based experiments. Automated cell counters equipped with advanced imaging and flow cytometry capabilities are meeting these needs by delivering high-resolution data and supporting complex assays, such as those involving heterogeneous cell populations. The integration of user-friendly software interfaces and data analysis tools further enhances the appeal of these systems, driving their adoption across laboratories and hospitals worldwide.

How Are Technological Advancements Transforming Cell Counting Techniques?

Technological advancements are transforming cell counting, improving both the accuracy and functionality of the tools available to researchers and clinicians. Innovations such as flow cytometry, image-based cell counting, and microfluidic devices are enabling more precise and high-throughput cell analysis. Flow cytometry, in particular, allows for the simultaneous counting and characterization of thousands of cells based on their physical and chemical properties, making it ideal for applications such as immunophenotyping and cancer research. Image-based cell counting, which uses advanced microscopy and software algorithms to analyze cell images, has become increasingly popular for its ability to provide detailed data on cell morphology and viability. Additionally, the emergence of label-free technologies, which allow for real-time monitoring of cell growth without the need for dyes or stains, is reducing the impact of external agents on the cells being studied, thus preserving their natural behavior. Automated systems that incorporate artificial intelligence (AI) and machine learning are further enhancing the capabilities of cell counting technologies, providing more accurate predictions and analysis of cellular behavior based on large datasets. These innovations are making cell counting faster, more reliable, and more versatile, expanding its applications in research and clinical diagnostics.

What Are the Key Growth Drivers in the Cell Counting Market?

The growth in the cell counting market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in biotechnology, and the growing demand for personalized medicine. One of the primary drivers is the rising need for accurate cell analysis in disease research and diagnostics. As the global incidence of cancer, diabetes, and infectious diseases continues to increase, cell counting technologies are essential for monitoring disease progression and evaluating the effectiveness of therapies. Additionally, the expansion of the biopharmaceutical industry, particularly in the production of biologics and vaccines, has intensified the demand for precise cell counting to ensure consistent product quality. Technological advancements, such as the development of automated, high-throughput cell counting systems, are further fueling market growth by improving the speed and accuracy of research workflows. The growing trend toward personalized medicine, which requires precise cell analysis to tailor treatments to individual patients, is also boosting demand for advanced cell counting technologies. Moreover, the increasing use of stem cells in regenerative medicine and the expansion of cell-based assays in drug development are creating new opportunities for cell counting solutions. Lastly, the adoption of cell counting technologies in clinical diagnostics, particularly in hematology and immunology, continues to drive market expansion as healthcare providers seek more accurate tools for patient care. These factors, combined with the growing investment in life sciences research, are expected to sustain the robust growth of the cell counting market in the coming years.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioTek Instruments, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Horiba Ltd.
  • Merck & Co., Inc.
  • PerkinElmer, Inc.
  • Siemens Healthineers
  • Sysmex Corporation
  • Tecan Group Ltd.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cell Counting - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Adoption of Automated Cell Counters Expands the Addressable Market for Cell Counting Solutions
    • Here's How Advancements in Flow Cytometry Propel Innovation in Cell Counting Methods
    • Growing Use of Cell Counting in Cancer Research Strengthens Market Demand
    • Rising Focus on Stem Cell Research and Therapy Spurs Adoption of Advanced Cell Counting Techniques
    • Here's How High-Throughput Screening in Drug Discovery Generates Demand for Automated Cell Counting
    • Technological Advancements in Image-Based Cell Counting Accelerate Market Growth
    • Growing Application of Cell Counting in Biologics and Vaccine Production Drives Demand
    • Rising Investments in Biotechnology and Life Sciences Propel Growth in Cell Counting Markets
    • Expanding Use of Cell Counting in Immunology and Infectious Disease Research Creates New Opportunities
    • Rising Incidence of Chronic Diseases Drives the Need for Accurate Cell Quantification in Clinical Diagnostics
    • Growing Adoption of Microfluidic Technologies Enhances Accuracy and Efficiency in Cell Counting
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Counting Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Counting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cell Counting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cell Counting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cell Counting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cell Counting by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Cell Counting by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cell Counting Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Cell Counting by Type - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Cell Counting by Type - Consumables and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Cell Counting by Type - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Cell Counting by End-Use - Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Cell Counting by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Hospitals, Clinical Laboratories, Pharma & Biotech Companies and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION